USING PROSTATE-SPECIFIC ANTIGEN TO ELIMINATE THE STAGING RADIONUCLIDE BONE SCAN
- 1 May 1997
- journal article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 24 (2) , 389-394
- https://doi.org/10.1016/s0094-0143(05)70385-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Mortality rates by stage-at-diagnosisSeminars in Surgical Oncology, 1994
- A reappraisal of serial isotope bone scans in prostate cancerThe British Journal of Radiology, 1993
- Prostate Specific Antigen and Bone Scan Correlation in the Staging and Monitoring of Patients with Prostatic CancerPublished by Wiley ,1992
- Levels of Prostate Specific Antigen that Predict Skeletal Spread in Prostate CancerPublished by Wiley ,1992
- Vertebral metastases and an equivocal bone scanNuclear Medicine Communications, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Bone Scanning and Plasma Phosphatases in Carcinoma of the ProstateBritish Journal of Urology, 1978
- The Role of Bone Scanning in the Assessment of Prostatic CarcinomaBritish Journal of Urology, 1978
- THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASESAnnals of Surgery, 1940